Πατήστε εδώ για τη συνέντευξη

NEJM

“A Monoclonal Antibody to PACAP for Migraine Prevention”
Ashina et al
NEJM, September 4, 2024

Lancet

1. “Migraine: disease characterisation, biomarkers, and precision medicine”
   Ashina et al. The Lancet. March 25, 2021.
2. “Migraine: epidemiology and systems of care”
   Ashina et al. The Lancet. March 25, 2021.
3. “Migraine: integrated approaches to clinical management and emerging treatments”
   Ashina et al. The Lancet. March 25, 2021.

Nature Reviews Neurology

1. “Diagnosis and management of migraine in ten steps”
   Eigenbrodt A.K., Ashina H., Khan S., Diener H-C., Mitsikostas D.D., et al.
   Nat Rev Neurol (2021). https://doi.org/10.1038/s41582-021-00509-5

Nature Reviews Disease Primers

1. “Tension-type headache”
   Ashina, S., Mitsikostas, D.D., Lee, M.J. et al.
   Nat Rev Dis Primers 7, 24 (2021). https://doi.org/10.1038/s41572-021-00257-2.
   

European Journal of Neurology

1. "European Academy of Neurology guidelines on the treatment of cluster headache"
   May, A, Evers, S, Goadsby, PJ, et al.
   Eur J Neurol. 2023; 00: 1-25. doi:10.1111/ene.15956

Δημοσιεύσεις της Ελληνικής Εταρείας Κεφαλαλγίας.

1. “A population-based survey for disabling headaches in Greece: Prevalence, burden and treatment preferences”
   Constantinidis, T.S., Arvaniti, C., Fakas, N., Rudolf J., Kouremenos E., Giannouli E., Mitsikostas D.D.
   Cephalalgia 2021 Jun;41(7):810-820. doi: 10.1177/0333102421989630
2. “The prevalence and burden of medication overuse headache in Greece.”
   Constantinidis TS, Arvaniti C, Fakas N, Rudolf J, Kouremenos E, Giannouli E. and Mitsikostas DD, on behalf of the Hellenic Headache Society.
   Cephalalgia 2023, Vol. 43(6) 1–11. Doi: 10.1177/03331024231184909
3. Patients' preferences for headache acute and preventive treatment.
   Mitsikostas DD, Belesioti I, Arvaniti C, Mitropoulou E, Deligianni C, Kasioti E, Constantinidis T, Dermitzakis M, Vikelis M; Hellenic Headache Society.
   J Headache Pain. 2017 Oct 6;18(1):102. Doi: 10.1186/s10194-017-0813-3.
4. Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine.
   Kouremenos E, Arvaniti C, Constantinidis TS, Giannouli E, Fakas N, Kalamatas T, Kararizou E, Naoumis D, Mitsikostas DD; Hellenic Headache Society.
   J Headache Pain. 2019 Dec 13;20(1):113. Doi: 10.1186/s10194-019-1060-6.
5. Validity and reliability of the Greek Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1-GR).
   Giannouli E, Giannouli E, Alexoudi A, Arvaniti C, Fakas N, Constantinidis TS, Kouremenos E, Mitsikostas DD; Hellenic Headache Society.
   J Patient Rep Outcomes. 2024 Jul 15;8(1):72. Doi: 10.1186/s41687-024-00762-4.
6. Hellenic Headache Society Recommendations for the Use of Monoclonal Antibodies Targeting the Calcitonin Gene Related Peptide Pathway for the Prevention of Migraine and Cluster Headache-2023 Update.
   Mitsikostas DD, Alexoudi A, Arvaniti C, Giannouli E, Kouremenos E, Constantinidis TS, Fakas N, Deligianni C, Karapanayiotides T, Dardiotis E, Gatzonis S, Konitsiotis S, Tsivgoulis G, Hellenic Headache Society.
   SN Comprehensive Clinical Medicine 2023;5:118. Doi: 10.1007/s42399-023-01452-w.
7. Consensus statement of the Hellenic Headache Society on the diagnosis and treatment of migraine.
   Constantinidis TS, Arvaniti C, Giannouli E, Kalamatas T, Kararizou E, Kouremenos E, Naoumis D, Fakas N, Mitsikostas DD.
   Archives of Clinical Neurology, Vol. 29 No. 2 (2020): Volume 29, No. 2, 2020
8. Hercules: a real-world study on the effectiveness and tolerability of anti-CGRP prophylactic treatments for migraine.
   Protocol of the ongoing national multicenter registry by the hellenic headache society.
   Constantinidis TS, Kouremenos E, Giannouli E, Fakas N, Arvaniti C, Kalamatas T, Dardiotis E, Konitsiotis S, Mitsikostas DD.
   Archives of Clinical Neurology, Vol. 34 No. 4 (2025): Volume 34, Issue 4, 2025.